Ani Pharmaceuticals (ANIP) Debt Ratio (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Debt Ratio of 0.21 for Q1 2026, little changed sequentially from 0.21 in Q4 2025, and down 12.32% YoY from 0.24 in Q1 2025.
Ani Pharmaceuticals (ANIP) Debt Ratio (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Debt Ratio for 15 years, with the latest figure at 0.21 in Q1 2026.
- Quarterly Debt Ratio fell 12.32% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (down 12.32% YoY) and the FY2025 annual result came in at 0.21, down 13.39% from the prior year.
- Debt Ratio was little changed at 0.21 in Q1 2026 per ANIP's latest filing, from 0.21 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.39 in Q3 2022 and troughed at 0.21 in Q4 2025.
- A 5-year average of 0.3 and a median of 0.31 in 2024 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio rose 0.91% in 2022, then dropped 27.42% in 2025.
- Over 5 years, Debt Ratio stood at 0.38 in 2022, then declined by 12.6% to 0.33 in 2023, then decreased by 24.56% to 0.25 in 2024, then dropped by 13.39% to 0.21 in 2025, then advanced by 0.04% to 0.21 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.21, 0.21, and 0.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.12 |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.20 |
| Mar 31, 2026 | 0.21 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.25 |
| Sep 30, 2024 | 0.24 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.38 |
| Sep 30, 2022 | 0.39 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.43 |